GE Healthcare has unveiled a new AI tool, CareIntellect for Oncology, to save doctors time when diagnosing and treating cancer. This application gives oncologists quick access to critical patient data, allowing them to focus more on patient care than sifting through complex medical records.
Doctors have long struggled with analyzing large amounts of healthcare data. A Deloitte report highlights that 97% of hospital data often goes unused, leaving physicians to manually sort through multiple formats like images, lab results, clinical notes, and device readings. CareIntellect for Oncology aims to solve this issue by helping doctors navigate the overload efficiently.
“It’s very time-consuming and frustrating for clinicians,” said Dr. Taha Kass-Hout, GE HealthCare’s global chief science and technology officer, in an interview with CNBC. The new tool will summarize clinical reports and flag deviations from treatment plans, like missed lab tests, so that doctors can intervene quickly.
AI Solutions
Oncology treatments are complicated and can span several years with numerous doctor visits. CareIntellect for Oncology helps physicians track their patients’ journeys, freeing them from administrative tasks. According to Kass-Hout, it also assists in identifying clinical trials for cancer patients, a process that typically takes hours of work.
“We’ve removed that burden,” said Chelsea Vane, GE HealthCare’s vice president of digital products. This feature alone could save doctors significant time, allowing them to concentrate on more pressing matters.
CareIntellect for Oncology also gives doctors flexibility. They can view original records for deeper insights, ensuring access to detailed patient data when needed.
The tool will be available to U.S. customers in 2025, focusing first on prostate and breast cancers. Institutions like Tampa General Hospital are already testing the cloud-based system, which will generate recurring revenue for GE HealthCare. The company also plans to expand CareIntellect’s capabilities with additional AI tools.
GE Healthcare is developing five more AI products, including an AI team, to help doctors make quicker, more informed decisions. One tool aims to predict aggressive breast cancer recurrences, while another flags suspicious mammograms for radiologists.
These AI-powered innovations aim to ease the burden on clinicians and elevate patient care. Kass-Hout believes these tools can provide the same level of support as a multidisciplinary team, with the added benefit of instant availability.
“Our goal is to raise the standard of care and relieve overburdened clinicians,” said Kass-Hout.
With CareIntellect for Oncology, GE HealthCare is taking a significant step in using AI to support medical professionals and improve patient outcomes. This technology could shape the future of cancer care, offering hope to doctors and patients.
